Catalyst Wire Dossier Catalyst Wire Dossier

Runihol

· POLYSAN Scientific & Technological Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Runihol, covering 2019-02-08 to 2019-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome [Phase 2]

See pricing